<DOC>
	<DOCNO>NCT00842699</DOCNO>
	<brief_summary>The goal study find effect two different drug use begin organ transplantation different population immune cell body patient .</brief_summary>
	<brief_title>Characterization Immunological Profile Renal Transplant Patients Undergoing Induction Treatment With Thymoglobulin vs. IL-2 Receptor Antagonist Basiliximab</brief_title>
	<detailed_description />
	<mesh_term>Basiliximab</mesh_term>
	<criteria>patient consider transplantation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>